endovastec™ completes its first implantation of castor™ branched stent-云顶国际

recently, the first implantation of the castor™ branched aortic stent-graft and delivery system (castor™ branched stent-graft) and hercules™ thoracic stent graft with low profile delivery system covered stent (hercules™-lp stent graft) developed by endovastec™, was completed at tan tock seng hospital by professor glenn tan, professor pua uei, professor lawrence quek, and their team. this marks the first clinical use of endovastec™’s products in singapore.

the patient, diagnosed with a thoracic aortic aneurysm during a preoperative assessment, had a twisted and narrowed distal neck, a lengthy affected area, a large aneurysm with a maximum diameter exceeding 70 millimeters, and exhibited noticeable symptoms. this necessitated a thoracic endovascular aortic repair (tevar). after a comprehensive evaluation of the patient's imaging data and related measurements, the medical team decided to perform the surgery using a combination of castor™ branched stent-graft and hercules™-lp stent graft, thereby establishing a more reliable, healthy anchoring zone when isolating the aneurysm.

the operation proceeded smoothly and postoperative angiography revealed precise positioning of the castor™ branched stent-graft, effectively isolating the aneurysm. the near-end triple small wave segment of the stent displayed excellent sealing without any endoleak or stent migration, and the blood flow in the supra-arch branch vessels remained unobstructed, resulting in a successful surgery.

thus far, castor™ branched stent-graft has been introduced into clinical application in 16 countries worldwide, successfully treating over 18,000 patients, and hercules®-lp stent graft has been introduced into clinical application in 18 countries globally, effectively treating more than 58,000 patients with aortic diseases.endovastec™ will continue its unwavering commitment to advancing comprehensive medical solutions for aortic and peripheral vascular diseases, bringing more high-quality, innovative products to global markets.

about castor™ branched stent-graft and hercules™-lp stent graft

castor™ branched stent-graft is designed for endovascular treatment of thoracic aortic dissection involving arch lesions and is the first approved branched aortic stent-graft for the market worldwide. meanwhile, hercules™-lp stent graft adopts a low-profile design, which can adapt to narrower and more tortuous access arteries. it is mainly suitable for endovascular treatment of thoracic aortic aneurysm or stanford type b thoracic aortic dissection.